Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium citrate
- Development stage
- Unknown
- Lead developer
- Norwell
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cystoplus is an over-the-counter urinary alkalizing agent containing sodium citrate as its active ingredient. Developed and marketed by Norwell Consumer Healthcare (an affiliate of Pharmascience), it is indicated for the symptomatic relief of burning pain and stinging associated with cystitis (urinary bladder inflammation) in adult women. Sodium citrate works by raising the pH of urine, making it less acidic and thereby reducing the discomfort of dysuria during urination. Cystoplus is typically supplied as cranberry-flavored powder sachets to be dissolved in water and taken orally over a 48-hour course.
- Brand names
- Cystoplus
- Other names
- sodium citrate dihydratetrisodium citratetrisodium citrate dihydrate
Beyond the preview
Go deeper on sodium citrate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium citrate.